Allopregnanolone Caproate (NEW) – 100mg/mL

Research Areas

• Sustained mood elevation and rapid anxiety relief
• Faster sleep onset and deeper sleep quality
• Enhanced social fluency and interpersonal connection
• Targeted neuroprotection via superior brain-barrier partitioning
• Next-generation antidepressant action beyond SSRIs
  
  

Recommended Dose: 

• 10-70mg per week
  
  

Shipping Details

• Secure, tamper-proof bubble-wrap packaging
• Dispatched via registered courier (tracking link emailed within 3 business days)
• Estimated delivery 5–14 business days (varies by location) 

• Post-Finasteride Syndrome (PFS) – 5α-reductase inhibition directly blocks allopregnanolone synthesis
• Major depressive disorder (MDD) – Depressed patients show reduced allopregnanolone
• Post-traumatic stress disorder (PTSD) – PTSD patients had allopregnanolone levels less than 39% of healthy controls
• Postpartum depression (PPD) – Allopregnanolone drops rapidly after childbirth
• Chronic stress and burnout – Prolonged stress downregulates 5α-reductase expression by ~50%, reducing allopregnanolone
• Traumatic brain injury (TBI) – Allopregnanolone reduced cell death and brain inflammation, improving functional recovery
• Alzheimer’s disease – Weekly allopregnanolone preserved hippocampal volume in high-risk patients
• Parkinson’s disease – Allopregnanolone restored dopamine-producing neurons and improved motor function
• Alcohol use disorder – Chronic alcohol use depletes brain allopregnanolone